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Abstract
Background: The innate immune response is the first line of defence against invading pathogens and is regulated
by complex signalling and transcriptional networks. Systems biology approaches promise to shed new light on the
regulation of innate immunity through the analysis and modelling of these networks. A key initial step in this
process is the contextual cataloguing of the components of this system and the molecular interactions that
comprise these networks. InnateDB (http://www.innatedb.com) is a molecular interaction and pathway database
developed to facilitate systems-level analyses of innate immunity.
Results: Here, we describe the InnateDB curation project, which is manually annotating the human and mouse
innate immunity interactome in rich contextual detail, and present our novel curation software system, which has
been developed to ensure interactions are curated in a highly accurate and data-standards compliant manner. To
date, over 13,000 interactions (protein, DNA and RNA) have been curated from the biomedical literature. Here, we
present data, illustrating how InnateDB curation of the innate immunity interactome has greatly enhanced network
and pathway annotation available for systems-level analysis and discuss the challenges that face such curation
efforts. Significantly, we provide several lines of evidence that analysis of the innate immunity interactome has the
potential to identify novel signalling, transcriptional and post-transcriptional regulators of innate immunity.
Additionally, these analyses also provide insight into the cross-talk between innate immunity pathways and other
biological processes, such as adaptive immunity, cancer and diabetes, and intriguingly, suggests links to other
pathways, which as yet, have not been implicated in the innate immune response.
Conclusions: In summary, curation of the InnateDB interactome provides a wealth of information to enable
systems-level analysis of innate immunity.
Background
The immune system is traditionally divided into two dif-
ferent branches - the adaptive immune system, the arm
of the immune system that mounts a specific response
to foreign antigens, and the innate immune system. The
importance of the innate immune response is now well
recognised as the first, and perhaps even the most criti-
cal, line of defence against invading pathogens and there
has been an explosion of interest in investigating it.
Innate immunity is fast-acting by comparison to the
adaptive response, which can take several days to
respond, and furthermore, innate immunity instructs,
regulates and shapes the subsequent adaptive response
[1,2].
Despite the lack of antigen specificity present in adap-
tive immunity, components of the innate immune system
can still distinguish between a broad range of pathogens
and mount an appropriate response. Receptors of the
innate immune response, known as pathogen recognition
receptors (PRRs), recognise specific molecular motifs or
signatures (often called pathogen-associated molecular
patterns or PAMPs) expressed by invading pathogens
[3], including lipopolysaccharide (LPS), peptidoglycan,
lipoteichoic acid, lipopeptides, flagellin, bacterial CpG
DNA and viral nucleic acids.
The best-studied family of PRRs in humans are the
Toll-like receptors (TLRs) [4], however, the importance
of other PRRs including the nucleotide-binding oligo-
merization domain (NOD)-like receptors (NLRs) [5,6],
* Correspondence: david.lynn@teagasc.ie
1Animal & Bioscience Research Department, AGRIC, Teagasc, Grange,
Dunsany, Co. Meath, Ireland
Full list of author information is available at the end of the article
Lynn et al. BMC Systems Biology 2010, 4:117
http://www.biomedcentral.com/1752-0509/4/117
© 2010 Lynn et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
and the retinoic acid-inducible gene I (RIG-I)-like recep-
tors (RLRs) is becoming evident [7,8]. NLRC4, for exam-
ple, has recently been shown to be involved in the
recognition of components of the bacterial type III
secretion system, enabling the discrimination between
pathogenic and non-pathogenic bacteria [9]; while the
recognition of microbiota peptidoglycan by Nod1 has
been shown to enhance systemic innate immunity [10].
The RIG-I pathway has been shown to have a critical
role in the response to a range of viral pathogens
[11-13].
Recently, we have reviewed the complexity of the
innate immune response and have argued that innate
immunity does not involve simple linear pathways, but
rather complex networks of molecular interactions and
transcriptional responses [14]. Over the last three years,
we have developed InnateDB (http://www.innatedb.
com), a database of the molecular interactions and path-
ways involved in innate immunity and an analysis plat-
form enabling systems-level analysis of the innate
immune response [15]. A key component of the Inna-
teDB project is the contextual manual curation of innate
immunity interactions, pathways and their component
molecules. In our original article on InnateDB, approxi-
mately 3,500 molecular interactions had been curated
[15]. Currently (July 2010), more than 13,000 interac-
tions of relevance to innate immunity have been anno-
tated. Given this significant progress, now is an
appropriate time to review the InnateDB curation pro-
cess and our novel customised software that enables
curation in a data-standards and ontology compliant
manner and to highlight some of the new insights that
are being revealed through curation of the innate immu-
nity interactome.
Why the need for curation?
Systems biology approaches reflect the biological reality
that complex cellular processes like the immune
response are not regulated by straightforward linear
pathways but by networks of complex molecular interac-
tions [14]. To undertake systems-level analyses of the
innate immune response, one must first have a catalo-
gue of the components of the system and how they
interact with each other. Generating such a catalogue is
complicated by the fact that the interactome is a
dynamic entity, in which the interactions that occur are
dependent on their context. Such contextual considera-
tions include the cell and/or tissue type, the environ-
mental or experimental conditions including the
presence of specific stimuli, the species, the time-point,
etc. Additionally, the level of confidence that an interac-
tion actually occurs (and has biological relevance) in
vivo can be dependent on a number of factors. These
include the interaction detection method, whether the
interaction was detected in vitro or in vivo, on addi-
tional experimental approaches used to validate the
interaction, and whether the interaction has been inde-
pendently reported by other research groups.
Several large-scale efforts to identify all possible mole-
cular interactions that make up the interactome are well
under way in several species [16-19], including human
[20]. Although these efforts are enormously valuable,
they are not without their limitations. Many of these
projects, for example, are focused on protein-protein
interactions and rely heavily on yeast two-hybrid
approaches, which can be associated with high false
positive and false negative rates [21]. Furthermore, such
approaches do not provide detailed contextual insight
into which interactions occur under particular condi-
tions or in which cell-types.
In addition to these large-scale efforts, a large number
of interactions are reported in the biomedical literature.
These usually involve relatively low-throughput investi-
gations of interactions between a handful of molecules,
but are nonetheless, a valuable source of data for defin-
ing the interactome. Although there may only be a few
interactions reported in each publication, there are
thousands of such publications. Critically, such publica-
tions frequently report rich contextual information on
the interaction, and interactions are often validated
using several different experimental approaches. Thus,
extracting annotation on such interactions from the lit-
erature can be extremely valuable. Although literature
mining approaches potentially provide a high-through-
put, low cost approach to extracting information and
annotation from the literature [22], such approaches can
be highly inaccurate, often rely on text in an abstract
rather than the full-text, and do not substitute for cura-
tion by a trained curator.
Several databases have now been established as reposi-
tories for molecular interaction data including the Mole-
cular Interaction database (MINT) [23]; the IntAct
database [24]; the Database of Interacting Proteins (DIP)
[25]; the General Repository for Interaction Datasets
(BioGRID) [26] and the Biomolecular Interaction Net-
work Database (BIND) [27]. Each of these has similar
quality and data standards requirements to InnateDB
and have been integrated into InnateDB to provide a
comprehensive framework of the entire human and
mouse interactomes. IntAct, DIP, MINT and BioGRID
have active literature curation efforts and are members
of the International Molecular Exchange Consortium
(IMEx) (http://www.imexconsortium.org/), which aims
to synchronise curation efforts to avoid redundancy.
InnateDB is now an observer member of this consor-
tium and is working towards full active membership.
The sheer scale of the task involved in curating inter-
actions from the literature, however, means that even a
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large consortium, such as IMEx, must focus its efforts to
particular journals and publications. Indeed, several of
the partner databases concentrate their curation efforts
on papers published in fewer than ten journals. Impor-
tantly from an immunology perspective, neither the
journals that are routinely curated nor the databases
themselves have a specific focus on the immune system,
and in particular, not on the innate immune system.
Therefore, the majority of interactions of relevance to
innate immunity are not annotated by these efforts (see
Figure 1 for evidence thereof). Additionally, investigation
of the pathways and molecular interactions involved in
innate immunity is a fast-moving field, with an explo-
sion of publications in recent years and new interactions
being reported on an almost daily basis.
To address these issues and to undertake a curation
process that has a specific interest in the innate immune
system, the InnateDB project has had a full-time cura-
tion team employed for more than three years. As of
February 15th 2010, there were 11,786 InnateDB-
curated molecular interactions in InnateDB (>3,000 pub-
lished articles reviewed) and an additional 117,066
(mostly non-overlapping) interactions integrated from
other databases. This integration of molecular interac-
tions from other databases provides broad coverage of
the entire human and mouse interactomes - the innate
immunity relevant portion of this interactome is then
enriched through curation by the InnateDB team. Cur-
rently, InnateDB only curates interactions involving
human and mouse molecules, with the majority of
curated interactions (72% or 8,569 interactions) invol-
ving human molecules (although there has been no spe-
cific focus on human as opposed to mouse).
Additionally, there are 1,005 hybrid interactions invol-
ving both human and mouse participants. Curated inter-
actions are primarily protein-protein interactions (9,244
interactions), however, there are also almost 2,500 pro-
tein-DNA interactions and a small, but important, num-
ber of RNA interactions (mainly microRNAs).
MicroRNAs are now being recognised as key regulators
of innate immunity [28].
Results and Discussion
InnateDB Curation Greatly Enhances Innate Immunity
Relevant Networks
The 11,500+ curated interactions can be grouped into
7,985 non-redundant interactions (based on the same
participants and interaction type). Of these, 6,882 (86%)
were curated only by InnateDB, while 1,103 also have
been curated by one of the other databases integrated
into InnateDB (Figure 1). As illustrated, without the
InnateDB curation efforts there would be a significant
paucity in the innate immunity interactome available for
systems-level analyses.
InnateDB also enhances pathway-specific networks
providing a more comprehensive picture of pathway sig-
nalling than traditional pathway diagrams. Figure 2 illus-
trates this point for the RIG-I signalling pathway, a key
pathway in the anti-viral innate immune response [7].
The KEGG pathway database [29] depicts RIG-I signal-
ling in a clear linear fashion that would be recognisable
to most biologists (Figure 2A). If, however, we use Inna-
teDB to construct a network of all the possible interac-
tions between components of this pathway (Figure 2B),
we can see that such pathway diagrams are a convenient
simplification of the inter-connectivity and likely cross-
talk between pathway components. Curated InnateDB
information greatly enhances this network-orientated
perspective of innate immunity signalling pathways.
Over half of the interactions illustrated (>200) have
been curated solely by InnateDB. Furthermore, if we
expand upon this view (Figure 2C) and visualise all
potential molecular interactions involving components
of this pathway, one can clearly see the potential for
Figure 1 The InnateDB-curated innate immunity interactome.
A) A network of all interactions in the InnateDB-curated innate
immunity interactome. B) The subset interactions in Figure 1A
which were curated only by InnateDB in comparison to the BIND,
DIP, MINT, IntAct and BioGRID databases (i.e. >80%). C) Interactions
in A which were also curated by the BioGRID, BIND, DIP, MINT or
IntACT databases. This figure illustrates how InnateDB curation
greatly enhances our knowledge of innate immunity-relevant
interaction networks, a key step in systems-level analyses.
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Figure 2 The RIG-I signalling pathway. A) KEGG pathway diagram of the RIG-I pathway. B) A network of all InnateDB annotated molecular
interactions between components of the RIG-I pathway highlights the additional level of complexity that is not conveyed in the KEGG diagram.
Edges coloured red represent phosphorylation interactions; edges coloured blue represent protein-DNA interactions. C) A network of all
InnateDB annotated molecular interactions between components of the RIG-I pathway and all other annotated interaction partners reveals the
potential for cross-talk between RIG-I pathway components and many other molecules and pathways. Networks were constructed using
InnateDB (http://www.innatedb.com/batchSearchInit.jsp) and were visualised in Cytoscape 2.6.3 using the Cerebral plugin.
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huge complexity in the signalling response and cross-
talk and/or interchange between a large number of
other molecules and pathways.
Innate Immunity Hub and Bottleneck Proteins
The network of InnateDB curated human interactions
was analysed using the cytoHubba plugin [30] (http://
hub.iis.sinica.edu.tw/cytoHubba/) for Cytoscape 2.6.3
[31] to investigate a variety of properties of this network
including the identification of network hubs and bottle-
necks (see below for definitions), which are likely to
represent the key regulatory nodes in the network. The
top 50 hubs (i.e. highly connected nodes) in this net-
work were identified by using the “Degree” algorithm
(Table 1). The hub nodes were, in particular, highly
enriched for proteins involved in the TLR and NFB
signalling pathways [MYD88, TRAF6, IRAK1, CHUK
(IKBKA), IKBKB, IKBKG (NEMO), NFKB1, RELA,
MAP3K7 (TAK1), etc]. In addition to the NFB tran-
scription factor subunits, a number of IRF and STAT
transcription factors were identified as hubs. There were
also a number of hub proteins that do not currently
have known roles in innate immunity. These provide
potentially new regulators of innate immunity that war-
rant further investigation.
The Hubba software also allows one to predict pro-
teins that act as bottlenecks in the network. Bottlenecks
are network nodes that are the key connector proteins
in a network and have many “shortest paths” going
through them [32]. The majority of hub proteins were
also identified amongst the top 50 bottlenecks (Table 1).
Intertwining Networks
The InnateDB curated interactome includes more than
2,000 human genes and more than 1,000 mouse genes.
The InnateDB pathway and Gene Ontology tools have
been used to investigate the pathways and biological
processes which are statistically over-represented in this
dataset. Given that the majority of interactions in Inna-
teDB involve human molecules, we have focused these
analyses on human genes (Additional file 1). Unsurpris-
ingly, a range of innate immunity pathways are statisti-
cally over-represented in this dataset, including TLR,
RIG-I, NLR and other pathways (Additional file 2). Per-
haps highlighting an increased appreciation of the links
between innate and adaptive immunity [2], several path-
ways of relevance to adaptive immunity were also over-
represented, including T and B cell receptor signalling
pathways. This network of genes and proteins involved
in both innate and adaptive immunity underscores the
interconnectivity of the two systems.
Interestingly, the network is also enriched in pathways
annotated to be involved in cancer (e.g. KEGG pathways
- Pathways in cancer; Prostate cancer; Pancreatic cancer;
Colorectal cancer; Chronic myeloid leukaemia). This
may be due to overlap between these cancer pathways
with apoptosis (also over-represented) and other rele-
vant pathways such as TGFb signalling [33]. The impor-
tance of apoptosis in the innate immune response is
well known [34,35], however, the connection between
innate immunity and cancer is now also becoming more
established [36,37].
Other interesting over-represented pathways include
the Insulin signalling pathway, Wnt signalling, Ubiquitin
mediated proteolysis, and Endocytosis among many
others (Additional file 2). Intriguingly, there is growing
evidence of an contribution of a dysregulated innate
immune response to diabetes [38]. Links between Wnt
signalling and innate immunity are also becoming
apparent [39], while the involvement of ubiquitin
mediated proteolysis and endocytosis in innate immu-
nity are well known [40,41].
The InnateDB curated genes are also over-represented
in pathways that do not have well established links to
innate immunity, for example, the neurotrophin path-
way. Neurotrophins are a family of proteins involved in
neural cell differentiation and survival and may be
involved in Alzheimer’s disease [42]. So far, there is only
limited evidence of a relationship between neurotro-
phins and inflammation [43]. Although there are likely
to be several reasons why this pathway would be over-
represented in the InnateDB curated interactome, it is
tempting to speculate about links between innate immu-
nity and this pathway. The InnateDB interactome pro-
vides a wealth of data for further investigation of the
links between innate immunity and other processes and
pathways.
Gene Ontology analysis paints a similar picture to the
pathway analysis with terms such as innate immune
response, inflammatory response, response to virus, apop-
tosis, cytokine activity, and signal transduction all being
in the top 20 most statistically significant terms (Addi-
tional file 3). Reassuringly, innate immune response is
the most over-represented term (corrected P = 2e-163).
Other terms such as protein kinase activity and nucleo-
tide binding reflect the large number of phosphorylation
and protein-DNA interactions curated by InnateDB.
Transcriptional Regulation
The InnateDB curation team has annotated more than
2,500 protein-DNA interactions. Aside from these
curated interactions, we have also investigated which
transcription factor binding sites are over-represented in
the promoter regions of human genes in the InnateDB
curated interactome (Additional file 4). Perhaps unsur-
prisingly, given the central role of NFB in innate
immunity [44], binding sites for its subunits are the
most statistically over-represented. The interferon
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Table 1 Top 50 hub nodes in the InnateDB-curated human innate immunity interactome
Gene InnateDB ID Ensembl ID Entrez ID Degree BottleNeck
RELA IDBG-57543 ENSG00000173039 5970 104 *
CTNNB1 IDBG-27347 ENSG00000168036 1499 92 *
IRF1 IDBG-42125 ENSG00000125347 3659 92 *
TRAF6 IDBG-40102 ENSG00000175104 7189 90 *
STAT1 IDBG-77617 ENSG00000115415 6772 86 *
AKT1 IDBG-22709 ENSG00000142208 207 81 *
NFKB1 IDBG-31974 ENSG00000109320 4790 75 *
IKBKB IDBG-19987 ENSG00000104365 3551 71 *
EP300 IDBG-8992 ENSG00000100393 2033 70 *
CHUK IDBG-243385 ENSG00000213341 1147 65 *
IRAK1 IDBG-90782 ENSG00000184216 3654 55 *
MAPK1 IDBG-2147 ENSG00000100030 5594 54 *
IRF3 IDBG-63225 ENSG00000126456 3661 51
MAP3K7 IDBG-94374 ENSG00000135341 6885 50 *
TRAF2 IDBG-92817 ENSG00000127191 7186 49 *
ERBB2IP IDBG-24405 ENSG00000112851 55914 48 *
SNTA1 IDBG-66573 ENSG00000101400 6640 48 *
SQSTM1 IDBG-61811 ENSG00000161011 8878 47 *
STAT3 IDBG-50702 ENSG00000168610 6774 46 *
IKBKG IDBG-91846 ENSG00000073009 8517 45 *
REL IDBG-53133 ENSG00000162924 5966 45
NFKBIA IDBG-4758 ENSG00000100906 4792 44 *
IRF2 IDBG-46310 ENSG00000168310 3660 42
CASP3 IDBG-46394 ENSG00000164305 836 41 *
PRKCZ IDBG-86108 ENSG00000067606 5590 41 *
BIRC3 IDBG-69045 ENSG00000023445 330 40 *
IRF4 IDBG-55681 ENSG00000137265 3662 40 *
IRF8 IDBG-45278 ENSG00000140968 3394 40 *
MAPK8 IDBG-73479 ENSG00000107643 5599 40 *
MTOR IDBG-89258 ENSG00000198793 2475 40 *
CASP8 IDBG-78534 ENSG00000064012 841 38 *
IL8 IDBG-23954 ENSG00000169429 3576 38 *
IRF7 IDBG-17225 ENSG00000185507 3665 38
JUN IDBG-99221 ENSG00000177606 3725 38 *
MAPK14 IDBG-84613 ENSG00000112062 1432 38 *
XIAP IDBG-85142 ENSG00000101966 331 38 *
MAVS IDBG-49080 ENSG00000088888 57506 36 *
IKBKAP IDBG-79889 ENSG00000070061 8518 35 *
TSC1 IDBG-90470 ENSG00000165699 7248 35 *
BIRC2 IDBG-69075 ENSG00000110330 329 34
RAF1 IDBG-19277 ENSG00000132155 5894 34 *
CUL1 IDBG-46918 ENSG00000055130 8454 33 *
HRAS IDBG-16878 ENSG00000174775 3265 33 *
RIPK1 IDBG-57326 ENSG00000137275 8737 33 *
GZMB IDBG-4054 ENSG00000100453 3002 32 *
NFKB2 IDBG-87893 ENSG00000077150 4791 32
PIK3R1 IDBG-25037 ENSG00000145675 5295 32 *
MAPK3 IDBG-25745 ENSG00000102882 5595 31
MYD88 IDBG-25713 ENSG00000172936 4615 31
PAK1 IDBG-65610 ENSG00000149269 5058 31
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regulatory factor, IRF8, is also over-represented [45].
Other IRFs, including IRF1, IRF2 and IRF7 are over-
represented but these are only statistically significant
prior to correction for multiple testing. Similarly, prior
to correction for multiple testing, there are many other
well-known innate immunity relevant transcription fac-
tors over-represented including CREB1, CEBPB, AP1
and STAT1. In addition to these, there are a number of
other transcription factors that do not have well known
roles in innate immunity and would be potentially inter-
esting to investigate in this context. ATF6, for example,
does not have a well defined role in innate immunity.
This ER stress-regulated transcription factor, however, is
a key component of the unfolded protein response
(UPR), which is induced in response to and can be
modulated by several viruses and bacterial toxins
[46-48]. ATF4, which is also over-represented, is also
involved in this response [49]. A key link between the
UPR and innate immunity in C. elegans has very
recently been demonstrated [50].
MicroRNA Regulation of Innate Immunity
The importance of microRNAs (miRNAs) as regulators
of innate immunity is now becoming clear [28]. We
have used the DIANA-mirExTra web server (http://
www.microrna.gr/mirextra) [51] to identify miRNA tar-
get motifs that are over-represented in our curated
human gene dataset. Due to the short size of the
miRNA motifs, a large number of miRNAs were identi-
fied as over-represented (Additional file 5). These
include miRNAs with known roles in innate immunity
or inflammation. miR-105, for example, has been shown
to regulate the protein expression of TLR2 in human
keratinocytes [52], while miR-182 expression is a bio-
marker for patients with sepsis [53]. Others have roles
in pathways enriched in the InnateDB curated interac-
tome, including miR-200 which regulates insulin signal-
ling [54], and miR-101 and miR-214 that are involved in
cancer [55,56]. As with the other preliminary analyses
discussed above, this dataset provides a wealth of infor-
mation to identify new potentially important regulators
of innate immunity.
The Curation Process
The goal of manual curation in InnateDB is to accu-
rately and richly annotate molecular interactions and
pathways of relevance to the innate immune system in
human and mouse and as demonstrated above this cura-
tion process provides an invaluable data source for
investigating innate immunity. Given that the quality of
this resource is dependent on our curation process, a
discussion of the InnateDB curation approach and our
novel software, which enables accurate, standardised
curation, is warranted.
Details of molecular interactions are extracted through
review of relevant publications in the biomedical litera-
ture. Curation is primarily carried out in a pathway-
centric way, whereby curators systematically review all
of the available literature describing interactions that
involve members of a particular innate immunity path-
way (e.g. RIG-I signalling). Review articles, pathway
databases and other sources are used to define the com-
ponents of a pathway and then all molecular interac-
tions between these genes and their encoded products
and any other molecule (protein, DNA, RNA) are
reviewed and curated. Molecular interactions for each
pathway member are systematically curated, although
priority is given to publications and experiments that
are not already described in InnateDB (or the other
integrated databases). Importantly, interactions are
curated between molecules in the pathway and all other
interactors regardless of whether the interacting mole-
cule is a member of the pathway or has any known role
in innate immunity. This allows InnateDB to expand on
linear views of pathways to develop a more comprehen-
sive interaction network perspective, highlighting poten-
tial cross-talk between pathways and/or prospective
novel pathway members (Figure 2).
This pathway-centric process increases curation effi-
ciency as one publication often describes molecular
interactions involving several different pathway mole-
cules. Systematically curated pathways are scheduled for
frequent re-curation as the field is moving quickly. In
addition to this approach, new publications on innate
immunity are also assessed on a daily basis to identify
novel interactions of interest. Priority is given to the
most recent publications, ensuring that InnateDB has a
fast turnaround time for incorporating new information
on the most current research into the database. Further-
more, the focus of curation efforts on a specific area (i.e.
innate immunity) rather than on curating all molecular
interactions in general is of significant benefit - ensuring
that the curation team develops considerable expertise
in assessing the relevant publications and in-depth
knowledge of the field.
The InnateDB Curation Software System
The InnateDB curation system (http://www.innatedb.
com/dashboard) is a novel web-based platform that has
been designed as part of the curation project to allow
the submission of detailed contextual annotation on
each interaction to the database in a manner that is
compliant with the recently proposed “minimum infor-
mation required for reporting a molecular interaction
experiment” (MIMIx) guidelines [57], and in compliance
with the Proteomics Standards Initiative Molecular
Interaction (PSI-MI) 2.5 XML format [58]. Such annota-
tion includes the supporting publication; the participant
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molecules; the molecule type; the organism; the biologi-
cal role; the interaction detection method; the host sys-
tem (in vitro, in vivo, ex vivo); the host organism; the
interaction type; the cell, cell-line and tissue types; cell
status (primary/cell line); the experimental role; the par-
ticipant identification method and sub-cellular
localisation.
The curation system is implemented using the open-
source framework CakePHP (http://cakephp.org). On
the web interface of the system, browser-side scripting
technology with JavaScript and JQuery are utilised to
provide a more interactive user experience. Submitted
interactions are stored in a MySQL database and are
migrated to the public database tables on a weekly basis.
Note that a user account is required to use the system.
The system has been designed to minimise the
amount of free-text information that needs to be
entered by the curator and instead, it utilises, where
possible, a series of drop-down menus of PSI-MI [59],
Open Biomedical Ontology (OBO) [60] or Gene Ontol-
ogy [61] controlled vocabulary terms (Figure 3). There
are only 4 free-text fields of the 20+ fields that are used
to curate an interaction. Two of these fields relate to
additional comments that curators can record, such as
Figure 3 The InnateDB curation system - interaction submission page.
Lynn et al. BMC Systems Biology 2010, 4:117
http://www.biomedcentral.com/1752-0509/4/117
Page 8 of 14
details of any experimental conditions relevant to
detecting the interaction. Such comments include, for
example, stimulation with a particular cytokine, infor-
mation on mutations, tags, etc. Another free-text field is
the full name for the interaction for which we have
established a standard format. The fourth free-text field
is for the PubMed ID (PMID), however, this must be
validated before it will be accepted by the system. When
a curator enters a PMID, the abstract for this PMID is
automatically retrieved from NCBI and displayed. The
curator must then confirm that this is the correct
abstract before the PMID will be entered.
Interaction Participants
An interaction may have two participants, in the case of
binary interactions, or multiple participants in the case
of complexes. Self interactions are annotated as binary
interactions with the same participant. Network and
pathway visualisation in InnateDB is carried out using
Cerebral (Cell Region-Based Rendering And Layout)
[62]. Cerebral is a plugin for the Cytoscape biomolecular
interaction viewer [31] that generates more biologically
intuitive pathway-like layouts of networks using subcel-
lular localisation and other annotation. In the version of
Cerebral launched from InnateDB, complexes are dis-
played as separate nodes with each participant shown as
an interaction with the complex. Such edges are labelled
‘X is part of complex Y’. In this way, nodes representing
complexes can be linked to other interactions in the
network without inferring binary interactions between
all participants in a complex.
Each interaction participant is linked to InnateDB via
a unique, stable, InnateDB molecule ID, which maps
one-to-one with identifiers from the Ensembl database
(http://www.ensembl.org). When a curator adds a parti-
cipant, they enter the gene/protein name into a search
field, InnateDB is then searched for all matching gene/
protein synonyms (both symbols and full names are
searched). Although HGNC (HUGO Gene Nomencla-
ture Committee) symbols are used for human partici-
pants [63] and Mouse Genome Database (MGD)
symbols for mouse participants [64], all known syno-
nyms, full-names and other details for the participant
are displayed for the curator. This reduces incidences of
confusing alternative gene names. InnateDB also pro-
vides extensive cross-references to other major databases
(CCDS, EMBL, Ensembl, Entrez Gene, HPRD, HUGO,
OMIM, RefSeq, UniProt).
As mentioned, InnateDB currently only includes inter-
actions involving human or mouse molecules. Hybrid
interactions involving human and mouse participants
are allowed. If no information about the participant spe-
cies can be gathered from the paper or in other
references, the authors of the paper are contacted to
provide this information.
Interaction Types
The most common interaction type among curated
interactions is “physical association”, however, there are
also many more specific interaction types including over
700 phosphorylation interactions, more than 300 clea-
vage interactions, 85 ubiquitination interactions, and
smaller numbers of other biochemical interactions
including sumoylation, methylation, and acetylation
interactions. There are also over 300 transcriptional reg-
ulation interactions in InnateDB. These interactions
must be supported by evidence showing physical pro-
tein-DNA binding and evidence that this binding alters
transcription, for example, through a luciferase assay.
Interaction Evidence
Each interaction, which is defined by the participant
molecules and the interaction type, may have multiple
lines of interaction evidence associated with it. Interac-
tion evidence refers to the experimental procedures and
conditions that were reported to support the interaction.
The same interaction may be supported by multiple dif-
ferent publications or different experiments reported in
the same publication. For convenience, interactions with
multiple lines of evidence are grouped into a single non-
redundant entry on the InnateDB website. For detailed
discussion of how evidence is curated in InnateDB
please see the curation manual (http://www.innatedb.
com/doc/InnateDB_2010_curation_guide.pdf).
Interaction Evidence - which journals are curated?
To date, more than 3,000 journal articles have been
curated by InnateDB curators (see http://www.innatedb.
com/statistics.jsp for up-to-date statistics). The curation
team does not focus their efforts to any specific journals -
relevant articles are curated regardless of the journal in
which they are published as long as they meet the appro-
priate quality standards for the interaction evidence.
Indeed, at least one article has been curated from >200
different journals. That said, more than 70% of curated
articles have come from 20 journals (Figure 4). It is worth
noting that many of the journals in this top 20 would not
be considered to be immunology journals, underscoring
the importance of not limiting curation efforts to journals
perceived as “relevant”. More than 800 articles, for exam-
ple, have been curated from the Journal of Biological
Chemistry.
The majority of curated articles have been published
in the last decade (>80%), with no particular year being
particularly over-represented in this time-frame (200-
300 curated articles in each year from 2000 - 2009).
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Almost all other curated articles were published in the
late 1990’s.
Interaction Evidence - Cell & Tissue Types
The interactome is not a single static entity and is very
much dependent on the context of the particular cell-
type under investigation, thus detailed contextual anno-
tation of interactions has the potential to be very
valuable. Although curated interactions in InnateDB are
annotated in a wide range of cell and tissue types, the
majority of these interactions stem from studies invol-
ving cell lines (87%) rather than primary cells. For pri-
mary cell interactions, macrophages represent the most
prevalent cell-type, although less than 200 interactions
have been recorded. Epithelial cell derived lines are the
most abundant cell line (~30%). Additionally, there are
approximately 300 macrophage cell line interactions.
What is clear is that cell-type specific interaction maps
are not currently feasible from this type of data and
large-scale efforts to map the interactomes of particular
cell-types are urgently required.
Interaction Evidence - Interaction Detection Methods
Curated interactions in InnateDB are supported by a
broad range of interaction detection methods, including
X-ray crystallography, yeast two-hybrids and GST pull-
downs. The most abundant detection method, however,
is coimmunoprecipitation which accounts for nearly half
of all evidence.
Annotating Innate Immunity Genes
Aside from annotating innate immunity interactions and
pathways, the InnateDB curation team has also begun to
annotate which genes have a role in the innate immune
response. This was initiated because Gene Ontology
annotation [61] of the innate immune response is lim-
ited to a quite small number of genes, and our effort
reflects a desire in the research community to have a
defined list of innate immune genes. For innate immune
gene annotation, curators employ an internal annotation
tool in the InnateDB curation system to associate rele-
vant genes with publications that provide evidence of a
role of a given gene in innate immunity. In addition to
a link to the relevant publication(s), the curators provide
a one-line summary of the role, similar to Entrez Gen-
eRIFs (http://www.ncbi.nlm.nih.gov/projects/GeneRIF/
GeneRIFhelp.html). Such genes are also automatically
associated/tagged with the Gene Ontology term “innate
immune response” in InnateDB, providing a more com-
prehensive list of such genes for use by the InnateDB
Gene Ontology over-representation analysis tool. This is
an on-going process but, to date, more than 500 genes
have been annotated. It is not intended for InnateDB to
comprehensively annotate all of the roles of a given
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Figure 4 Number of articles curated by the InnateDB curation team in the top 20 journals.
Lynn et al. BMC Systems Biology 2010, 4:117
http://www.biomedcentral.com/1752-0509/4/117
Page 10 of 14
gene, but rather to provide a brief indication as to
whether the gene has a role in innate immunity.
Reliability of Manual Curation
It has been suggested that curation of protein interac-
tion datasets “can be error prone and possibly of lower
quality than commonly assumed” [65]. This assertion
appears to be based largely on subjective reliability cri-
teria such as the low overlap between curated datasets
in various different databases. In response to this asser-
tion, members of the IMEx consortium have pointed
out that the low overlap between databases in this con-
sortium is quite intentional [66]. To avoid unnecessary
redundancy, several of these databases coordinate their
curation efforts. Furthermore, the IMEx consortium
showed that curation error rates in their databases are
in the region of 2-9% in comparison to the close to 50%
error rate suggested by Cusick et al [65].
Similarly, the InnateDB curation team focuses on
interactions that have not already been curated in any of
the databases integrated into InnateDB, unless those
interactions are supported by an additional un-reviewed
article or there is additional annotation that could be
added. Therefore, the limited overlap between InnateDB
and other databases is intentional, avoids redundancy
and reflects the database’s focus on innate immunity
(Figure 1). Consistent with the IMEx consortium cura-
tion process, InnateDB aims to accurately represent data
on interactions presented in the literature. The curation
team avoids, as much as possible, subjective calls on the
quality of the evidence supporting an interaction unless
that evidence is clearly insufficient to support the claims
in the publication or does not support a direct physical
or biochemical interaction.
Conclusions and Methods
Challenges of Curation
The process of experimentally verifying molecular inter-
actions can offer many challenges in completing full
MIMIx-compliant annotation for each InnateDB sub-
mission. The absence of key information from publica-
tions often impedes the curation procedure, reducing
the annotation available to accurately portray a molecu-
lar interaction. The incorrect or absent identification of
the source organism of a participant molecule was
recently reported as a common error in many external
interaction databases [65]. In particular, many publica-
tions describing molecular interactions do not clarify
whether they are referring to a human or to a mouse
gene/protein. Over the approximately 90 million years
that evolutionarily separate human and mouse [67],
there have been substantial changes to their respective
signalling networks, and an interaction in one species
does not guarantee it will occur in the other. Databases
like InnateDB, therefore, must distinguish between
human and mouse molecules. In many cases, informa-
tion regarding the organism in question is reported in
the supplemental data or in referenced material, requir-
ing a great deal of effort to track down. In a number of
cases, direct correspondence with the authors is the
only option available to the curators to verify such infor-
mation. Thankfully, most authors are more than willing
to reply. It is not uncommon, however, for authors to
be themselves uncertain. Journal editors and peer
reviewers must be encouraged to ensure that such
details are clearly specified in papers.
An important step in the right direction in this regard
is the collaboration between the MINT database and the
FEBS Letters journal [68,69]. This collaboration involves
the processing of accepted articles prior to publication
by MINT curators to create a structured digital abstract,
which describes the interactions in the paper in detail.
This process involves the manuscript authors in the
curation process.
Another key challenge for curation is the fact that
molecules can have several common names, which can
lead to ambiguity in annotating the participant mole-
cules in an interaction. A prominent example in the
innate immunity area is the gene encoding the TLR
adaptor protein, TIRAP. This gene is also frequently
known as MAL. The official HGNC name [63] for this
gene is TIRAP, however, there is another completely dif-
ferent gene with the HGNC name, MAL. One can see
the potential for confusion. If provided in the paper, the
curators use gene/protein accession numbers to confirm
the gene in question - this should be strongly encour-
aged by journal editors and reviewers. As discussed
above, the curation system also displays all synonyms,
full-names and other details for a curator to view when
annotating a participant molecule. This approach high-
lights cases where there are two or more genes with
similar/same names, allowing curators to review care-
fully which gene they are referring to. Another related
issue is identifying which specific protein isoform is
described in an experiment. At present, this is often
impossible to tell. Therefore, all interactions in Inna-
teDB are mapped back to the parent gene ID, with
annotation on the molecule type (e.g. protein) involved.
Other challenges to curation include evolving stan-
dards. PSI-MI [59] and OBO terms [60], describing
interaction types, detection methods, cell-types, etc, are
not static and a term that is valid today may be depre-
cated or replaced in the future. Similarly, not all relevant
terms have been described in ontologies yet; new inter-
action detection methods, for example, may not be spe-
cified. Additionally, not all fields have standardised
ontologies. Cell lines, for example, do not have a stan-
dardised OBO ontology. InnateDB adheres to using cell
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line names from the American Type Culture Collection
(http://www.atcc.org) where possible, however, this list-
ing is not comprehensive. An additional issue regarding
cell lines include cases where different cell lines may
have the same or very similar names.
While these and other issues provide notable chal-
lenges to the curation team, the InnateDB curation sys-
tem, its detailed guide on the curation process, and
regular meetings to discuss potential pitfalls, ensures
that InnateDB has a very high standard of curation. As
discussed, InnateDB curation of innate immunity rele-
vant interactions, pathways and genes is providing the
most comprehensive picture yet of the innate immune
interactome, and promises to shed new light into its
regulation and how pathogens can evolve to subvert it.
Additional material
Additional file 1: Details of the 2089 human genes which are
interaction participants in the InnateDB curated interactome.
Additional file 2: Pathway analysis of the 2089 human genes which
are interaction participants in the InnateDB curated interactome
revealing which pathways are statistically over-represented in the
innate immunity interactome.
Additional file 3: Gene Ontology analysis of the 2089 human genes
which are interaction participants in the InnateDB curated
interactome revealing which GO terms are statistically over-
represented in the innate immunity interactome.
Additional file 4: Transcription factor binding site analysis of the
2089 human genes which are interaction participants in the
InnateDB curated interactome revealing which transcription factor
binding sites are statistically over-represented in the promoter
regions of these genes.
Additional file 5: MicroRNA target motifs which are statistically
over-represented in the 2089 human genes which are interaction
participants in the InnateDB curated interactome.
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